Overexpression of cMOAT (MRP2/ABCC2) is associated with decreased formation of platinum-DNA adducts and decreased G2-arrest in melanoma cells resistant to cisplatin

Resistance to various anti-neoplastic agents is a common observation in clinical management of melanoma. The biologic mechanisms conferring these different drug-resistant phenotypes, including resistance against the commonly used anti-cancer drug cisplatin, are unclear. In order to elucidate the rol...

Full description

Saved in:
Bibliographic Details
Main Authors: Liedert, Bernd (Author) , Schadendorf, Dirk (Author)
Format: Article (Journal)
Language:English
Published: 8 December 2015
In: The journal of investigative dermatology
Year: 2003, Volume: 121, Issue: 1, Pages: 172-176
ISSN:1523-1747
DOI:10.1046/j.1523-1747.2003.12313.x
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1046/j.1523-1747.2003.12313.x
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0022202X15303080
Get full text
Author Notes:Bernd Liedert, Verena Materna, Dirk Schadendorf, Jürgen Thomale, Hermann Lage
Description
Summary:Resistance to various anti-neoplastic agents is a common observation in clinical management of melanoma. The biologic mechanisms conferring these different drug-resistant phenotypes, including resistance against the commonly used anti-cancer drug cisplatin, are unclear. In order to elucidate the role of the membrane adenosine triphosphate binding cassette-transporter cMOAT (canalicular multispecific anion transporter) (MRP2/ABCC2) in cisplatin resistance of melanoma, the expression of this protein was analyzed in the platinum drug-resistant cell line MeWo CIS 1. Cisplatinresistant melanoma cells showed a distinct overexpression of cMOAT on mRNA and protein level. This observation was accompanied by a reduced formation of platinum-induced intrastrand cross-links in the nuclear DNA measured by an immunocytologic assay. This decrease in DNA platination was accompanied by an accelerated re-entry into the cell cycle after the typical cisplatin-induced G2 arrest, and a resistance to undergo apoptosis. Kinetics of formation and elimination of platinum-DNA adducts suggest that the DNA repair capacity for Pt-d(GpG) adducts was not elevated in platinum drug-resistant melanoma cells. The decrease in platinum-DNA adduct formation in cisplatin-resistant melanoma cells was rather a reflection of the protecting activity of the transporter cMOAT. In conclusion, the functional inhibition of cMOAT might be a promising strategy in the reversal of resistance to platinum-based anti-cancer drugs in human melanoma.
Item Description:Elektronische Reproduktion der Druckausgabe
Im Titel ist die Zahl 2 im Ausdruck "G2-arrest" tiefgestellt
Gesehen am 23.11.2020
Physical Description:Online Resource
ISSN:1523-1747
DOI:10.1046/j.1523-1747.2003.12313.x